Alzheimer's & Dementia

Alzheimer’s disease risk genes modulate interferon-responsive microglia.

Relationships between KLOTHO and APOE4-associated ß-amyloid and tau alterations across AD continuum.

Klotho protein concentrations as a function of sex, APOE, family history or Alzheimer’s disease biomarker status in an at-risk cohort.

Pathological Validation of RORB and CDH9 as Selectively Vulnerable Neurons in Alzheimer’s Disease.

The Lonafarnib target, Rhes, is uniquely dysregulated in tauopathies: A human postmortem study.

TAU-MEDIATED CELL DEATH MECHANISMS IN MAPT V337M IPSC-DERIVED HUMAN NEURONS.

ASTROGLIAL AND MICROGLIAL MODULATION OF NEURAL FUNCTIONS IN MODELS OF ALZHEIMER’S DISEASE.

A NOVEL ROLE FOR THE FTD-CAUSING PROTEIN PROGRANULIN IN APOPTOSIS SIGNALING.

POST-TRANSLATIONAL MODIFICATIONS OF TAU IN ALZHEIMER'S DISEASE: A POSTMORTEM STUDY IN HUMANS.

ACETYLATED TAU DISTRIBUTION IN THE HUMAN HIPPOCAMPUS.

Pages